Derwent external registry name |
DR9509214
|
Derwent preferred name |
SILDENAFIL
|
|
Activity keywords |
PHOSPHODIESTERASE-INHIBITORS; VASODILATORS
|
|
International non-proprietary name |
SILDENAFIL
|
|
Ave molecular weight |
474.583
|
|
Conference |
210th American Chemical Society National Meeting, Chicago, Illinois, USA, 20 - 24 August 1995.
|
Fast-Track Ref. No. |
NCE-95-1151
|
Presentation Details |
Lecture, MEDI 229
|
WDA Reference No. |
WD-95-024805
|
|
Adverse effects |
EYE-DISEASE: vision-disorder; MISC.: dizziness; MISC.: dyspepsia; MISC.: headache; MISC.: vertigo.; MISC.: rash; MISC.: nasal-congestion; MISC.: flushing
|
|
Precautions and warnings |
Determine underlying causes; abnormal penile anatomy; leukemia.; priapism; sickle-cell-anemia; retinitis-pigmentosa; multiple-myeloma; hemorrhagic-disorder; conditions predisposing to priapism; active peptic ulcer; cardiac-risk
|
|
Interactions |
Amyl-nitrate; cimetidine; erythromycin; ketoconazole; nitrates.; mibefradil; itraconazole; diuretics
|
|
Contraindications |
Hypersensitivity; severe hepatopathy; recent myocardial infarction or cerebrovascular accident; pre-existing cardiac conditions where sexual activity is inadvisable; hypotension; hereditary degenerative retinal disorders.
|
|
Mechanism of action |
PHOSPHODIESTERASE-V-INHIBITOR
|
|
Derwent update code |
1995.4-1999.4
|
|
Substructure keywords |
BH-LINKED-CC; COND.RING; PHENOL-ETHER; LACTAM; PYRAZOLE; SULFONAMIDE; PYRIMIDINE; PIPERAZINE
|
|
2D-coordinates |
66 numerical data |
|
Derwent Molform |
C22 H30 N6 O4 S
|
|
Indications and usage |
PENIS-DISEASE: erectile-dysfunction; PENIS-DISEASE: erection-disorder.
|
|
Country |
AU,CH,DE,ES,FI,FR,GB,JP,PH,TW,US,HK,SG,MY
|
|
|